BR112019006336A2 - beta-caseínas e a microbiota intestinal - Google Patents

beta-caseínas e a microbiota intestinal

Info

Publication number
BR112019006336A2
BR112019006336A2 BR112019006336A BR112019006336A BR112019006336A2 BR 112019006336 A2 BR112019006336 A2 BR 112019006336A2 BR 112019006336 A BR112019006336 A BR 112019006336A BR 112019006336 A BR112019006336 A BR 112019006336A BR 112019006336 A2 BR112019006336 A2 BR 112019006336A2
Authority
BR
Brazil
Prior art keywords
beta
casein
caseins
gut microbiota
proline
Prior art date
Application number
BR112019006336A
Other languages
English (en)
Other versions
BR112019006336B1 (pt
Inventor
John Clarke Andrew
Mary Babidge Catherine
Ni Jiayi
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=61759958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112019006336(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Publication of BR112019006336A2 publication Critical patent/BR112019006336A2/pt
Publication of BR112019006336B1 publication Critical patent/BR112019006336B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C13/00—Cream; Cream preparations; Making thereof
    • A23C13/12—Cream preparations
    • A23C13/14—Cream preparations containing milk products or non-fat milk components
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/09—Other cheese preparations; Mixtures of cheese with other foodstuffs
    • A23C19/0917—Addition, to cheese or curd, of whey, whey components, substances recovered from separated whey, isolated or concentrated proteins from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
    • A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein
    • A23V2250/5424—Dairy protein
    • A23V2250/54246—Casein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)

Abstract

a melhora do equilíbrio da microbiota intestinal benéfica de um animal provendo uma composição contendo beta-caseína, em que pelo menos 75% em peso da beta-caseína é uma variante da beta-caseína que tem uma prolina na posição 67 da sequência de aminoácidos da beta-caseína.
BR112019006336-6A 2016-09-30 2016-09-30 Beta-caseínas e a microbiota intestinal BR112019006336B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NZ2016/050161 WO2018063008A1 (en) 2016-09-30 2016-09-30 Beta-caseins and gut microbiota

Publications (2)

Publication Number Publication Date
BR112019006336A2 true BR112019006336A2 (pt) 2019-06-25
BR112019006336B1 BR112019006336B1 (pt) 2021-09-21

Family

ID=61759958

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019006336-6A BR112019006336B1 (pt) 2016-09-30 2016-09-30 Beta-caseínas e a microbiota intestinal

Country Status (11)

Country Link
US (1) US11925197B2 (pt)
JP (1) JP6873234B2 (pt)
KR (2) KR20220040497A (pt)
AU (1) AU2016424981B2 (pt)
BR (1) BR112019006336B1 (pt)
CA (1) CA3036494C (pt)
MX (1) MX2019003636A (pt)
MY (1) MY186302A (pt)
PH (1) PH12019550035A1 (pt)
RU (1) RU2769989C2 (pt)
WO (1) WO2018063008A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118201501A (zh) * 2021-12-03 2024-06-14 N·V·努特里奇亚 用于改善婴儿微生物群的营养组合物
WO2024056784A1 (en) 2022-09-14 2024-03-21 N.V. Nutricia Nutritional composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU691362B2 (en) 1994-11-04 1998-05-14 New Zealand Dairy Board Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
WO1996036239A1 (en) 1995-05-16 1996-11-21 Corran Norman Stuart Mclachlan Food product and process
EP1196047A4 (en) * 1999-06-29 2004-12-22 New Zealand Milk Inst Ltd MILK-BASED PROPHYLACTIC FOOD SUPPLEMENTS
AU9037401A (en) 2000-09-08 2002-03-22 New Zealand Dairy Board Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders
US20060280802A1 (en) 2002-10-04 2006-12-14 Campbell Julie H Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
CN102123715B (zh) * 2008-06-13 2014-12-17 N.V.努特里奇亚 刺激免疫系统的营养物
JP6234227B2 (ja) * 2011-11-30 2017-11-22 株式会社明治 腸内菌叢改善用栄養組成物
CA2913890A1 (en) * 2013-05-31 2014-12-04 The A2 Milk Company Limited Beta-casein a2 and prevention of inflammation of the bowel
CN105431156A (zh) * 2013-07-12 2016-03-23 艾尔牛奶有限公司 β-酪蛋白A2和减轻或预防乳糖不耐受症状
KR102626825B1 (ko) * 2013-08-23 2024-01-17 디 에이2 밀크 컴퍼니 리미티드 베타-카세인 ａ２ 및 혈중 글루코스 수준
CN103918792A (zh) 2014-04-10 2014-07-16 陕西科技大学 一种木糖醇益生菌羊奶片及其制备方法
EP3297643A4 (en) * 2015-05-22 2019-02-06 The A2 Milk Company Limited BETA-CASEIN-A2 AND ANTIOXIDATIVE CAPACITY

Also Published As

Publication number Publication date
US20200008458A1 (en) 2020-01-09
RU2019107600A3 (pt) 2020-10-30
PH12019550035A1 (en) 2019-07-24
RU2019107600A (ru) 2020-10-30
CA3036494C (en) 2022-10-18
US11925197B2 (en) 2024-03-12
WO2018063008A1 (en) 2018-04-05
RU2769989C2 (ru) 2022-04-12
KR20190063463A (ko) 2019-06-07
BR112019006336B1 (pt) 2021-09-21
AU2016424981A1 (en) 2019-04-11
AU2016424981B2 (en) 2021-11-04
KR20220040497A (ko) 2022-03-30
CA3036494A1 (en) 2018-04-05
KR102431753B1 (ko) 2022-08-11
MY186302A (en) 2021-07-07
JP6873234B2 (ja) 2021-05-19
JP2019532645A (ja) 2019-11-14
MX2019003636A (es) 2019-06-17

Similar Documents

Publication Publication Date Title
ECSP17043316A (es) Polvo de coleópteros
CL2019000266A1 (es) Composición de cannabis.
BR112018006368A2 (pt) composição para desempenho melhorado
CO2018003134A2 (es) Composiciones para el cuidado bucal que comprenden un aminoácido básico, una combinación de fuentes de iones de zinc y un sistema quelante
BR112016015660A2 (pt) formulação farmacêutica de neuregulina (nrg) e formulação farmacêutica liofilizada de neuregulina (nrg)
CL2017002184A1 (es) Composición que comprende sialillactosa para usar en la mejora de las aptitudes de aprendizaje y la función de memoria.
BR112017027567A2 (pt) proteínas de fusão para inibir a angiogênese
BR112016024494A2 (pt) análogos de peptídeo com sonda(s) de aminoácidos ramificados
ECSP17043318A (es) Composición que contiene quitina y proteínas digeribles
BR112015029987A2 (pt) beta-caseína a2 e a prevenção de inflamação do intestino
BR112018076215A2 (pt) partículas e composições de nicotina
BR112019003785A2 (pt) tabaco resistente a vírus e método de melhoramento para o mesmo
BR112015018259A2 (pt) Redução de resposta pró-inflamatória
BR112017012714A2 (pt) composição de liberação modificada, método para tratamento ou prevenção de uma doença ou condição, e, método cosmético para reduzir peso corporal.
BR112017014361A2 (pt) métodos para aperfeiçoamento de terapia celular
BR112017006416A2 (pt) composição nutricional para meio gastrointestinal para proporcionar perfil aperfeiçoado de microbioma e metabólico
BR112014003640A8 (pt) métodos para perda de peso e composições cetogênicas
BR112017006180A2 (pt) composições de redução de mau odor
BR112018068817A2 (pt) beta-caseínas e função cognitiva
BR112017004223A2 (pt) método para induzir a síntese de ficobiliproteínas
BR112015023254A2 (pt) composições concentradas sólidas contendo zinco piritiona
BR112015018265A2 (pt) Composições nutricionais contendo um componente peptídico com propriedades estimulantes de adiponectina e utilizações das mesmas
CL2017001277A1 (es) Productos a base de sulfato de calcio resistentes al fuego
CO2020004801A2 (es) Uso de suplementos de aminoácidos para mejorar la síntesis de proteínas musculares
BR112019006336A2 (pt) beta-caseínas e a microbiota intestinal

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/09/2016, OBSERVADAS AS CONDICOES LEGAIS.